Androgens and estrogens are transported bound to the sex hormone binding globulin (SHBG). SHBG is believed to keep sex steroids inactive and to control the amount of free hormones that enter cells by passive diffusion. Contrary to the free hormone hypothesis, we demonstrate that megalin, an endocytic receptor in reproductive tissues, acts as a pathway for cellular uptake of biologically active androgens and estrogens bound to SHBG. In line with this function, lack of receptor expression in megalin knockout mice results in impaired descent of the testes into the scrotum in males and blockade of vagina opening in females. Both processes are critically dependent on sex-steroid signaling, and similar defects are seen in animals treated with androgen-or estrogen-receptor antagonists. Thus, our findings uncover the existence of endocytic pathways for protein bound androgens and estrogens and their crucial role in development of the reproductive organs.
Introduction
Steroid hormones are lipids with important regulatory functions. They exert main regulatory activities by entering target cells and associating with nuclear hormone receptors that, in turn, act as transcriptional acti-*Correspondence: an@biokemi.au.dk (A.N.); willnow@mdc-berlin.de (T.E.W.) 6 These authors contributed equally to the study. vators of steroid-responsive genes. Rather than being transported by lipoproteins like cholesterol, these cholesterol derivatives are bound by specific carrier proteins in the extracellular space. Such carriers include the sex hormone binding globulin (SHBG) and the corticosteroid binding globulin (CBG), transporters for sex steroids and corticosteroids, respectively (Hammond and Bocchinfuso, 1995; Scrocchi et al., 1993) . According to the free hormone hypothesis, only free steroids are biologically relevant, whereas carrier bound steroids are inactive because they are blocked from entering target cells (Mendel, 1989) .
Similar to steroid hormones, vitamins A and D are also transported by plasma carriers. Previously, these lipophilic metabolites were also believed to solely enter cells by free diffusion. However, we recently demonstrated the existence of endocytic pathways for tissuespecific uptake of the complexed vitamins. . Today, the significance of endocytosis of lipid/carrier complexes for tissue-specific delivery of vitamins A and D is well appreciated. However, this mode of lipid uptake is considered unique to the renal vitamin metabolism and perhaps not relevant for uptake of other carrier bound lipids such as steroid hormones.
Besides in the renal proximal tubules, megalin is expressed in a number of steroid-responsive tissues, in particular in the male and female reproductive organs (epididymis, prostate, ovaries, uterus) (Zheng et al., 1994) . This observation raises the intriguing possibility that the role of megalin may not be restricted to endocytosis of vitamins but may extend to the cellular uptake of steroid hormones such as androgens and estrogens. Previous experimental evidence suggested the existence of cell-surface binding sites for SHBG in steroid-responsive tissues including uterus, epididymis, and prostate. Their identity and their significance for sex-steroid activity remained controversial (Krupenko et al., 1994; Rosner et al., 1999; Turner and Roddy, 1990 ).
Here we investigated the possible role of megalin in the cellular delivery of sex steroids and the consequences of receptor deficiency for androgen and estro-gen action in vivo. We demonstrate that, in cultured cells, megalin internalizes complexes of sex steroids bound to SHBG. Following internalization, the carrier is degraded in lysosomes while the steroids are released to induce steroid-responsive genes. Lack of receptor expression in knockout mice results in testicular maldescent and vaginal obstruction, two phenotypes consistent with insensitivity of megalin-deficient tissues to androgen and estrogen signals.
Results
Androgen and estrogen binding proteins are present in most body fluids, the most common being SHBG, a homodimeric protein produced in the liver and secreted into the circulation in humans (Hammond and Bocchinfuso, 1995). In rodents, this protein is known as the androgen binding protein (ABP) that is mainly produced by the fetal liver (Sullivan et al., 1991) and by Sertoli cells of the adult testes (Feldman et al., 1981) . Because megalin is expressed in sex-steroid target tissues, we tested involvement of this receptor in the cellular uptake of steroid/SHBG complexes.
To do so, we developed a eukaryotic expression system to produce recombinant SHBG that closely resembles the native human protein in terms of steroid binding activity and ability to bind to membranes from steroidogenic tissues (Hilpert et al., 2001 ). Recombinant SHBG bound to purified megalin in vitro, as shown by surface plasmon resonance analysis ( Figure 1A ). The affinity of binding (K d = 200 nM) was similar to that of DBP to megalin . No SHBG binding was seen when the receptor was reduced, documenting specificity of the interaction ( Figure 1A) .
Brown Norway rat choriocarcinoma (BN16) cells express megalin but no related endocytic receptors (see Figure S1A in the Supplemental Data available with this article online). They are commonly used as a model system to evaluate cellular megalin activity. When SHBG was labeled with iodine and added to BN16 cells, efficient uptake and degradation of the protein was observed ( Figure 1B To explore the effect of this endocytic pathway for SHBG/ABP on the cellular metabolism of testosterone, we determined uptake of [ 3 H]testosterone in BN16 cells in the presence of unlabeled SHBG. After 5 hr, approximately 11% of the tracer was associated with the cells, a process that was blocked by RAP ( Figure 1C , filled columns). Megalin-mediated uptake of testosterone was critically dependent on the amount of SHBG present in the culture medium as shown by varying the molar ratio of carrier and testosterone ( Figure 1C, open columns) . At a ratio of carrier to steroid of 5:1 when 95% of the steroid is bound to SHBG ( Figure S2) Figure S2 ), cell association was independent of megalin and insensitive to RAP. At a molar ratio of 1:1 when 20% of testosterone is complexed ( Figure S2) , uptake was partially dependent on megalin activity ( Figure 1C ). In the human circulation (adult males), the ratio of SHBG to testosterone is approximately 3:1 (Turner et al., 1984) . SHBG bound testosterone was unable to enter cells when megalin was blocked by RAP and instead accumulated in the medium of the cells ( Figure 1D Figure 1E , open bars). Similar amounts of both tracers were detected in the cell fraction in a RAP-sensitive manner. The same finding was seen for testosterone/SHBG complexes ( Figure  1E , striped and hatched columns). Uptake of androgen/ SHBG complexes was also blocked by anti-megalin antiserum and by purified SHBG, confirming that the SHBG/ABP receptor megalin is responsible for steroid uptake ( Figure S3) Figure 1F ). Remarkably, keratinocytes that do not express megalin were unable to internalize significant amounts of complexed DHT or E2 ( Figure 1F ). The different abilities of BN16 cells and keratinocytes to accumulate bound steroids were not due to differences in nuclear-hormone-receptor profile because neither cell type expressed detectable levels of androgen or estrogen receptors ( Figure S1B) .
We confirmed the intracellular delivery of bound sex steroids through megalin-mediated endocytosis using confocal fluorescence microscopy. When FITC-labeled DHT was complexed with SHBG and added to BN16 cells, uptake and intracellular colocalization of FITC-DHT and SHBG was shown (Figure 2A) . Megalin was indispensable for this process, as cellular uptake of complexed FITC-DHT was blocked completely by RAP (Figure 2A ). Complexed steroids internalized via megalin were fully active in inducing an androgen-responsive luciferase reporter construct transfected into BN16 cells. In fact, 1 nM of SHBG bound DHT was at least as active in inducing the reporter as unphysiologically high equimolar amounts of free steroids added to the culture medium ( Figure 2B ). SHBG alone had no effect ( Figure  2B ). RAP inhibited gene induction by SHBG-complexed but not by free DHT (Figure 2C) Figure 3F ). In contrast, in adult megalin-deficient mice, the vagina opening was closed by a septum composed of an epithelial cell layer followed by connective tissue and skin (Figures 3G and 3H) . Similar features were seen in wild-type juvenile mice prior to sexual maturation ( Figures 3I and 3K ). E2 levels in megalin −/− females were similar to the levels in wild-type littermates ( Table  1 ), indicating that estrogen insensitivity rather than lack of estrogens was the underlying cause of this phenotype. As well as suffering from estrogen insensitivity, megalin-deficient mice also lack proper androgen signaling during development of the male reproductive organs. In all male receptor-deficient animals analyzed (n = 21), the left testis had not descended into the scrotum but was located in the body cavity (cryptorchidism). As a consequence of the unilateral testicular maldescent, the cryptorchid (left) testis was poorly developed and severely retarded in size ( Figure 4B ). Other aspects of the urogenitalia such as the contralateral testis, the epididymis, or the seminal vesicles exhibited normal appearance ( Figure 4B) . In histological sections, the cryptorchid testis was characterized by degenerated germinal epithelia of the seminiferous tubules and by the absence of germ cells ( Figure 4G ). The corresponding epididymis was devoid of sperm ( Figure 4H ). In contrast, the descended testis of knockout mice exhibited well-differentiated germinal epithelia ( Figure 4E ) and produced spermatozoa that filled the lumen of the epididymal ducts (Figure 4F ), identical to the situation in wild-type controls (Figures 4C and 4D) . Thus, megalin activity is not required for normal development and structural integrity of the male reproductive organs but is essential to control descent of the testes. Histological abnormalities in the cryptorchid testis are likely secondary to its exposure to a higher temperature in the abdomen.
Descent of the testes proceeds in two distinct steps. In early mouse embryos, the testes migrate from a position near the lower pole of the kidney to a region close to the bladder (transabdominal phase), while, after birth, the testes move further into the scrotum (inguinoscrotal phase) (Heyns and Hutson, 1995) . Defects in either phase of testicular descent cause cryptorchidism (Toppari and Kaleva, 1999). To identify what phase of the testicular descent was affected in megalin-deficient mice, we analyzed the urogenital tract in E18.5 (data not shown) and newborn animals ( Figure 5 ). In wild-type neonates, the testes were located near the bladder neck, consistent with completion of the transabdominal descent ( Figure 5A ). In contrast, in the megalin −/− newborns, both testes were positioned halfway between the kidney and the bladder ( Figure 5A ). Remarkably, an extensive ligament-like structure was apparent that fixed the gonads to the dorsal abdominal wall (arrow, Figure 5A ). This structure is the cranial suspensory ligament (CSL), one of two tissues that control the position of the gonads in both sexes. The second tissue is the gubernaculum, a structure that attaches to the caudal end of the gonads. Both ligaments are present in male and female embryos around midgestation. In females, the CSL persists and holds the ovaries in a position close to the kidney. In males, the primordium of the CSL regresses during development, and the gubernaculum "tracks" the testes toward the lower abdomen (Heyns and Hutson, 1995) analyzed the appearance of this ligament in wild-type and knockout embryos. In wild-type E14.5 male embryos, the CSL was still apparent as a thin tissue strand that connected the gonads with the craniolateral surface of the dorsal abdominal wall (Figure 6A ). At this time in development, megalin was expressed in the mesonephric tubules of the gonads in close proximity to the primordium of the CSL ( Figure 6B ). In receptordeficient E14.5 males, the CSL represented a thick cord-like structure ( Figure 6C ) that shared striking resemblance with the CSL of wild-type female embryos ( Figure 6D ). At earlier time points in development, no obvious difference in the histological appearance of wild-type and megalin −/− urogenital tissues was seen (data not shown). Failure of regression of the CSL in megalin-deficient male embryos was not due to a defect in androgen production. Rather, the amount of circulating testosterone and DHT was increased 2-fold compared to control littermates (Table 1) . Also, no discernable difference was seen in androgen levels in adult megalin −/− males compared to controls (Table 1) (Figure 7) . Normally, the ovaries of wild-type and megalin-deficient female E18.5 embryos are positioned laterally to the lower kidney pole ( Figures 7A and 7B) , with the CSL fixing the gonads to the dorsal body wall (Figures 7E and 7F ). When treated with exogenous DHT in utero, wild-type females induced regression of the CSL (Figure 7G ), displacing the ovaries from the lower kidney pole ( Figure 7C ). In contrast, megalin-deficient females responded poorly to DHT injection, with only partially displaced ovaries ( Figure 7D ) and clearly visible CSL ( Figure 7H ). In untreated wild-type male embryos, the gonads are located near the bladder in wild-types ( Figures 7I and 7N ) but tethered through aberrant CSL to the body wall dorsal to the kidney in knockouts (Figures 7K and 7O) . Application of exogenous DHT did not affect positioning of the gonads in wild-type males because endogenous androgen signaling is normal in these animals ( Figures  7L and 7P) . Similar to the females, megalin-deficient male embryos did not respond properly to exogenous androgen application and still exhibited abnormal persistence of the CSL ( Figure 7Q ) and maldescent of the gonads ( Figure 7M ). Similar findings were obtained by application of DHT propionate or testosterone (data not shown).
In conclusion, our findings in mice lacking megalin uncovered insensitivity to androgen and estrogen signaling as well as distinct defects in fetal and postnatal maturation of the reproductive organs. These phenotypes are highly reminiscent of defects induced by antiandrogens and anti-estrogens in rodents and strongly implicate this receptor pathway for SHBG/ABP in sexsteroid action in vivo.
Discussion
Until now, the identity and the role of proposed SHBG/ ABP receptors in steroid-hormone metabolism has remained obscure. We show that megalin is an endocytic receptor for SHBG/ABP in steroid target tissues that mediates uptake of carrier bound androgens and estrogens. When exposed to sex steroids in the presence of physiological concentrations of carrier proteins, cells are critically dependent on megalin activity to internalize significant amounts of the hormones. Little uptake is seen in the presence of megalin antagonists ( Figure  1C ) or in keratinocytes that lack receptor expression ( Figure 1F ). Bound steroids are delivered to intracellular compartments (Figure 2A ) and act as inducers of steroid target genes, the hallmark of cellular steroid action (Figures 2B and 2C) . Receptor interaction is solely dependent on the recognition of the carrier moiety by megalin and is independent of the presence of the steroid ( Figure 1B Thus, many studies on the cellular metabolism of steroid hormones were performed in the absence of carrier proteins or using hormone derivatives that do not interact with carriers. While these experimental conditions are useful to investigate intracellular aspects of steroid-hormone activity, they have drawn attention away from the physiological context where, depending on the steroid, as much as 95%-99.9% of the metabolites are complexed to proteins (Dunn et al., 1981) . Under these conditions, free diffusion may be of quantitatively lesser importance for cellular delivery of steroids, in particular in tissues that are in demand of large amounts of steroid hormones. Contrary to the aforementioned studies, we demonstrate that cells are able to internalize complexed sex steroids and to induce steroid target genes, provided that they express the SHBG/ABP receptor megalin. Although megalin is abundantly expressed in several absorptive epithelia in vivo, few established cell lines express the receptor. Thus, this SHBG/ABP uptake pathway may have been missed in previous studies using cells lacking the receptor.
Evidence for a physiological role of megalin in sexsteroid action stems from the defects observed in the receptor-deficient mouse model. Apart from bone disease as a consequence of hypovitaminosis D (Nykjaer et al., 1999), adult megalin −/− animals suffer from anomalies in genital maturation consistent with insensitivity to androgens and estrogens. Despite normal (E2) or even increased levels (testosterone, DHT) of circulating hormones, these mice exhibit defects seen in rodents treated with anti-androgens and anti-estrogens. Thus, female receptor null mice fail to induce opening of the vagina cavity, a benchmark of natural puberty. This process can be induced in the immature rodent by injection of E2 and blocked by application of anti-estrogens (Figure 7) , strongly supporting the concept that endocytic uptake of complexed steroids rather than free diffusion of unbound steroids is required to specifically deliver them to their target tissues.
Assuming a pivotal role of megalin in sex-steroid signaling, it is intriguing to note that megalin null mice do not share all of the anomalies seen in mice deficient for the AR (e.g., testicular feminization) (Couse and Korach, 1998; Hutson, 1986) or estrogen receptors (ER) (e.g., uterine hypoplasia) (Couse et al., 1999; Lubahn et al., 1993) . This observation suggests that megalin deficiency impairs spatially and temporarily restricted activities of androgens and estrogens in line with the distinct expression pattern of the receptor during genital development. In particular, activities that require apoptotic processes induced by paracrine action of steroid hormones may involve this receptor pathway. Thus, the exact molecular mechanism causing E2-induced opening of the vagina cavity is unclear at present, but it involves paracrine processes through tissues other than the vaginal epithelium itself. This hypothesis is based on the finding that blocking apoptosis in mice by overexpression of Bcl2 in epithelial and subepithelial cells of the vaginal mucosa results in vaginal obstruction, whereas Bcl2 expression in epithelial cells alone is insufficient (Rodriguez et al., 1997) . Similarly, local paracrine processes are also responsible for regulation of testicular descent. Although androgens play a causal role in this process, the hormones likely do not act on the CSL directly, as this tissue does not express detectable levels of AR (Emmen et al., 1998; Hutson et al., 1994) . Instead, androgens are believed to act on neighboring cell types (e.g., primordium of the CSL) that release paracrine factors such as epidermal growth factor, which has been shown to ameliorate the effects of flutamide application on descent of the testis (Cain et al., 1994) . The concept of paracrine action of steroids during testicular descent and vagina opening may explain why expression of megalin is seen not in the cell types that undergo apoptosis (CSL, vaginal epithelium) but in adjacent tissues such as mesonephric tubules and uterine epithelium (Figures 3C  and 6B) .
As well as acting in a locally restricted manner, steroid-induced opening of the vagina cavity and testicular descent are developmental processes that are induced during a very narrow time window in development, warranting the need for efficient steroid-uptake processes. This is best exemplified by the application of DHT analogs in pregnant rats to induce aberrant regression of the CSL in female embryos. In this model, involution of the CSL is seen when steroids are applied before E17 but not when they are applied at later embryonic stages (Emmen et al., 1998) . Because AR expression in rats starts around E16.5, this leaves a narrow time window for androgen action on the CSL. Similarly, application of flutamide showed maximal effect on testicular descent only when applied between E16 and E17 (Husmann and McPhaul, 1991) , a time when the AR is expressed in the mesenchymal and epithelial cells of the mesonephric tubules (where megalin is also seen).
In conclusion, our studies have uncovered endocytic pathways for cell-type-specific uptake of protein bound androgens and estrogens that are required for steroiddependent maturation of the reproductive organs. Our findings provide a novel paradigm for a biological role of carrier bound steroids in hormone action that may change current concepts in steroid-hormone biology. 
Experimental Procedures

Materials
Immunohistological Analysis
Urogenital tracts from embryos, neonates, or adult mice were dissected, fixed overnight in 4% paraformaldehyde in PBS at 4°C, and embedded in paraffin. Routine paraffin sections were cut at 5 m thickness and stained with hematoxylin and eosin. For megalin detection, unstained sections were incubated with sheep anti-megalin IgG (1:50,000) followed by peroxidase-conjugated rabbit antisheep antibody (1:100; Dako, Hamburg, Germany) and detection with diaminobenzidine.
Endocrine Analysis
Testosterone, DHT, and 17β-estradiol levels in adult plasma samples or E14.5 whole-embryo homogenates were determined using specific RIA (ICN Pharmaceuticals, Costa Mesa, California) or ELISA (for DHT; IBL, Hamburg, Germany) according to the manufacturers' recommendations following tissue extraction of the steroids by methanol and solid-phase extraction procedures . 
Gene-Expression Profiling
